|
| Wall Street Newscast |
Traders Newsletter
|
|
TWSI Combat Bandages May be Heading Back to Iraq
WASHINGTON - On Tuesday the Pentagon announced plans to send a special operations intelligence and strike force of between 100 and 150 troops to Iraq to conduct raids on Islamic State targets in Iraq and Syria, a senior Defense stated.
Defense Secretary Ash Carter told Congress about the extra troops Tuesday but did not specify how many. The Defense official spoke on condition of anonymity because officials were not authorized to comment publicly on details of the new force. The team will include intelligence analysts and special operations troops skilled in conducting raids, the source said.
This could put spotlight (OTC:TWSI), Hemcon Medical Technologies, Inc., which produces and sells blood control combat bandages that are in every US soldiers first aid kit on the battlefield.
Hemcon Medical Technologies is publicly traded division of TriStar Wellness Solutions, Inc. (OTCQB:TWSI)
TWSI hemostatic blood control bandages have saved countless US soldier lives in the previous Iraq war, with the company stating they had generated around $72 million in 2008 as the previous war in Iraq drew down.
Well, after the attack in Paris, it looks like the US may be heading back to war, and that may put TWSI as a stock to watch as the US gets more involved on the ground. No matter if its US boots, or if we arm the Kurds and Free Syrian Army, along with weapons will be medical equipment, like battlefield first aid kits....and that will include TWSI ChitoGause PRO combat bandages.
$300 Million Aid to Ukraine
In addition, the US 2016 Defense Budget that was recently passed included $300 million in non-lethal aid to troops fighting Russian forces in Eastern Ukraine. Among the aid provided was medical equipment, so wouldn't be surprised that also included first aid kits to troops, as TWSi also in standard in all NATO approved first aid combat kits.
TWSI currently has around 28 million shares issued and outstanding, with a market cap of only $2.8 million at price of $0.10 per share.
With new war on its way, and plans to provide equipment to our allies on the ground, TWSI may be heading higher as the US gets more involved on the ground in Iraq, Syria, and Ukraine.
About TriStar Wellness Solution, Inc.
Tristar Wellness Solution (OTCQB:TWSI), through is operating division HemCon Medical Technologies Inc., develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding are of critical importance. HemCon is headquartered in Portland, Ore. With a 36,000 sq. ft. state of the art manufacturing facility, the Company has additional commercial operations in Ireland and the Czech Republic. http://www.hemcon.com
|
|
|
About Wall Street Newscast
Located in New York City, Wall Street Newscast (WSNC) has been providing Wall Street investor presentations for both public and private companies since 1998. WSNC offers a wide-range of services to companies and investor relation professionals to discuss their recent news announcements, earnings reports, and corporate events to a diverse network of individual and institutional investors on Wall Street. www.wallstreetnewscast.com
Register online for our free traders newsletter at
www.wallstreetnewscast.com/form/newsletter.html
|
| Safe Harbor Statements:
This investor presentation may include statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
Disclaimer:
This is NOT a solicitation to Buy or Sell any security, but rather is for informational purposes only. Content contained herein includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Wall Street Newscast ("WSNC") does not guarantee the accuracy, completeness or timeliness of, or otherwise endorse these views, opinions or recommendations, or give investment advice. WSNC, its affiliates, or directors, may or may not hold a position in the above security from time to time, and investors are encourage to consider this as a possible conflict of interest when reviewing this information. In Compliance with SEC Rule 17B Wall Street Newscast was compensated fifthy thousand restricted shares, by the Company for media advisory services. WSNC may hold a position in above securities from time to time, and thus should be considered a possible conflict of interest when reviewing this report and information. These investments may involve a high degree of risk, thus investors are highly encouraged to consult with a financial advisor before any and all investments.
|
|
|
|
|
|
|
|
